234 related articles for article (PubMed ID: 23740526)
1. Impact of diabetes on platelet activation in different manifestations of atherosclerosis.
Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
Swiss Med Wkly; 2013; 143():w13800. PubMed ID: 23740526
[TBL] [Abstract][Full Text] [Related]
2. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
[TBL] [Abstract][Full Text] [Related]
3. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease.
Gremmel T; Koppensteiner R; Ay C; Panzer S
Eur J Clin Invest; 2014; 44(3):319-24. PubMed ID: 24382127
[TBL] [Abstract][Full Text] [Related]
4. In vivo and protease-activated receptor-1-mediated platelet activation but not response to antiplatelet therapy predict two-year outcomes after peripheral angioplasty with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Haemost; 2014 Mar; 111(3):474-82. PubMed ID: 24196591
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
Kohlmorgen C; Gerfer S; Feldmann K; Twarock S; Hartwig S; Lehr S; Klier M; Krüger I; Helten C; Keul P; Kahl S; Polzin A; Elvers M; Flögel U; Kelm M; Levkau B; Roden M; Fischer JW; Grandoch M
Diabetologia; 2021 Aug; 64(8):1834-1849. PubMed ID: 34131781
[TBL] [Abstract][Full Text] [Related]
6. In Vivo and protease-activated receptor-1-mediated platelet activation in patients presenting for cardiac catheterization.
Gremmel T; Michelson AD; Frelinger AL
Platelets; 2016 Jun; 27(4):308-16. PubMed ID: 26556638
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
8. Activation of calcium-dependent calmodulin by calcium(II)3(3,5-diisopropylsalicylate)6(H2O)6 decreases thrombin receptor activating peptide-induced P-selectin expression.
Homoncik M; Jilma B; Donham DC; Frossard M; Keuzer C; Sorenson JR
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):131-8. PubMed ID: 12632022
[TBL] [Abstract][Full Text] [Related]
9. Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Transl Res; 2013 May; 161(5):421-9. PubMed ID: 23340049
[TBL] [Abstract][Full Text] [Related]
10. Different Effects of Ranibizumab and Bevacizumab on Platelet Activation Profile.
Sobolewska B; Grimmel C; Gatsiou A; Sopova K; Klein J; Biedermann T; Stellos K; Ziemssen F
Ophthalmologica; 2015; 234(4):195-210. PubMed ID: 26305017
[TBL] [Abstract][Full Text] [Related]
11. Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis.
Gremmel T; Kopp CW; Eichelberger B; Koppensteiner R; Panzer S
Atherosclerosis; 2014 Dec; 237(2):692-5. PubMed ID: 25463107
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients.
Csongrádi É; Nagy B; Fulop T; Varga Z; Karányi Z; Magyar MT; Oláh L; Papp M; Facskó A; Kappelmayer J; Paragh G; Káplár M
Thromb Haemost; 2011 Oct; 106(4):683-92. PubMed ID: 21866298
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.
Furman MI; Benoit SE; Barnard MR; Valeri CR; Borbone ML; Becker RC; Hechtman HB; Michelson AD
J Am Coll Cardiol; 1998 Feb; 31(2):352-8. PubMed ID: 9462579
[TBL] [Abstract][Full Text] [Related]
15. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
16. Preserved thrombin-inducible platelet activation in thienopyridine-treated patients.
Gremmel T; Kopp CW; Seidinger D; Koppensteiner R; Steiner S; Panzer S
Eur J Clin Invest; 2013 Jul; 43(7):689-97. PubMed ID: 23611368
[TBL] [Abstract][Full Text] [Related]
17. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
18. Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.
Schmid W; Vogelsang H; Papay P; Primas C; Eser A; Gratzer C; Handler M; Novacek G; Panzer S
J Crohns Colitis; 2014 Jun; 8(6):495-503. PubMed ID: 24291018
[TBL] [Abstract][Full Text] [Related]
19. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition.
Badr Eslam R; Lang IM; Kaider A; Panzer S
Transl Res; 2013 May; 161(5):414-20. PubMed ID: 23313628
[TBL] [Abstract][Full Text] [Related]
20. Association of thrombin generation potential with platelet PAR-1 regulation and P-selectin expression in patients on dual antiplatelet therapy.
Badr Eslam R; Posch F; Lang IM; Gremmel T; Eichelberger B; Ay C; Panzer S
J Cardiovasc Transl Res; 2014 Feb; 7(1):126-32. PubMed ID: 24435325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
